We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Researchers Find Location of Pancreatic Cancer Gene

By Biotechdaily staff writers
Posted on 21 May 2002
A team of researchers has mapped the location of a gene associated with inherited pancreatic cancer to a large region called 4q32-34, and they expect to have the gene sequenced within a year. More...
Finding the gene will open new avenues for preventing, detecting, and treating the disease. The research appears in the early electronic edition of the April 2002 issue of the American Journal of Human Genetics.

Gathering sufficient genetic data was aided by the cooperation of Family X, the largest pancreatic-cancer family ever studied. Of the 20 family members affected (18 with pancreatic cancer or precancerous changes), nine have died of the disease, including five of six brothers. After genotyping the DNA samples from Family X, the researchers found that virtually every member of the family had a specific genetic marker on the long arm of chromosome 4, where the single-gene mutation responsible for pancreatic cancer is thought to be. None of the unaffected family members had this marker. Inherited pancreatic cancer accounts for about 10% of all cases.

The investigators were from the Fred Hutchinson Cancer Research Center (Seattle, WA. USA), the University of Washington School of Medicine (Seattle), and the University of Pittsburgh School of Medicine (PA, USA).

"Once the actual gene is found, if it turns out to be commonly mutated in all forms of pancreatic cancer—not just the inherited type—it could be used as a marker for broad screening,” said Leonid Kruglyak, Ph.D., a statistical geneticist at Fred Hutchinson. "Knowing and understanding the gene's pathways to cancer also could lead to new therapeutic developments.”





Related Links:
Fred Hutchinson
Univ. of Washington
Univ. of Pittsburgh

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.